Concepedia

Madhu Lal‐Nag

ML

23

Publications

1.7K

Citations

18

H-Index

2004

Active since

Affiliations

National Center for Advancing Translational Sciences(Current)

National Institutes of Health

Yale University

Johns Hopkins University

Frederick National Laboratory for Cancer Research

Madhu Lal‐Nag is an author at National Center for Advancing Translational Sciences specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

2004–2022

23

Publications

23

PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability

Berkley E. Gryder, Marielle E. Yohe, Hsien-Chao Chou et al. · Cancer Discovery · 2017 · 317 citations · Full text

Assay Guidance Manual [Internet]

Sarine Markossian, A Grossman, Kyle R. Brimacombe et al. · 2004 · 287 citations

, , +15

KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance

Kunihiko Hinohara, Hua‐Jun Wu, Sébastien Vigneau et al. · Cancer Cell · 2018 · 248 citations · Full text

, , +9

Cell Viability Assays -- Assay Guidance Manual

Sittampalam Gs, Ashley Grossman, Kyle R. Brimacombe et al. · 2004 · 170 citations

, , +4

Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity

Shyh‐Ming Yang, Natalia J. Martinez, Adam Yasgar et al. · Journal of Medicinal Chemistry · 2018 · 87 citations · Full text

, , +15

Rows per page

1–5 of 23